Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 344 entries
Sorted by: Best Match Show Resources per page
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine.

Rheumatology international

Collins A, Lendrem D, Wason J, Tarn J, Howard-Tripp N, Bodewes I, Versnel MA, Gottenberg JE, Seror R, Mariette X, Ng WF.
PMID: 34165604
Rheumatol Int. 2021 Sep;41(9):1593-1600. doi: 10.1007/s00296-021-04927-y. Epub 2021 Jun 24.

To re-analyse the clinical outcomes and interferon (IFN) activity data from the JOQUER trial, a phase III trial investigating hydroxychloroquine (HCQ) in patients with primary Sjögren's syndrome (pSS), after stratifying patients into putative pathobiological subgroups utilizing the Newcastle Sjögren's...

Cite
Collins A, Lendrem D, Wason J, et al. Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatol Int. 2021;41(9):1593-1600doi: 10.1007/s00296-021-04927-y.
Collins, A., Lendrem, D., Wason, J., Tarn, J., Howard-Tripp, N., Bodewes, I., Versnel, M. A., Gottenberg, J. E., Seror, R., Mariette, X., & Ng, W. F. (2021). Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatology international, 41(9), 1593-1600. https://doi.org/10.1007/s00296-021-04927-y
Collins, Alexis, et al. "Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine." Rheumatology international vol. 41,9 (2021): 1593-1600. doi: https://doi.org/10.1007/s00296-021-04927-y
Collins A, Lendrem D, Wason J, Tarn J, Howard-Tripp N, Bodewes I, Versnel MA, Gottenberg JE, Seror R, Mariette X, Ng WF. Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine. Rheumatol Int. 2021 Sep;41(9):1593-1600. doi: 10.1007/s00296-021-04927-y. Epub 2021 Jun 24. PMID: 34165604; PMCID: PMC8316226.
Copy Download .nbib Format: NLM
Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population.

Rheumatology international

Hardy C, Gladman DD, Su J, Rozenbojm N, Urowitz MB.
PMID: 34089358
Rheumatol Int. 2021 Aug;41(8):1457-1464. doi: 10.1007/s00296-021-04898-0. Epub 2021 Jun 05.

To estimate the level of medication adherence and barriers to adherence among systemic lupus erythematosus (SLE) patients. Patients taking antimalarials, immunosuppressives, and/or steroids to treat SLE were included. Adherence was measured using the Medication Adherence Self Report Inventory (MASRI)...

Cite
Hardy C, Gladman DD, Su J, et al. Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population. Rheumatol Int. 2021;41(8):1457-1464doi: 10.1007/s00296-021-04898-0.
Hardy, C., Gladman, D. D., Su, J., Rozenbojm, N., & Urowitz, M. B. (2021). Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population. Rheumatology international, 41(8), 1457-1464. https://doi.org/10.1007/s00296-021-04898-0
Hardy, Courtney, et al. "Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population." Rheumatology international vol. 41,8 (2021): 1457-1464. doi: https://doi.org/10.1007/s00296-021-04898-0
Hardy C, Gladman DD, Su J, Rozenbojm N, Urowitz MB. Barriers to medication adherence and degree of nonadherence in a systemic lupus erythematosus (SLE) outpatient population. Rheumatol Int. 2021 Aug;41(8):1457-1464. doi: 10.1007/s00296-021-04898-0. Epub 2021 Jun 05. PMID: 34089358.
Copy Download .nbib Format: NLM
ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia.

Rheumatology international

Goto M, Tsuchida Y, Terada K, Takahashi H, Sugimori Y, Komai T, Iwasaki Y, Shoda H, Fujio K.
PMID: 34156527
Rheumatol Int. 2021 Jun 22; doi: 10.1007/s00296-021-04923-2. Epub 2021 Jun 22.

Protein-losing enteropathy (PLE) has been reported to be associated with various systemic autoimmune diseases. However, reports regarding PLE in ANCA-associated vasculitis (AAV) patients are limited. We herein aimed to describe the clinical characteristics of AAV with PLE. We conducted...

Cite
Goto M, Tsuchida Y, Terada K, et al. ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04923-2.
Goto, M., Tsuchida, Y., Terada, K., Takahashi, H., Sugimori, Y., Komai, T., Iwasaki, Y., Shoda, H., & Fujio, K. (2021). ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia. Rheumatology international, . https://doi.org/10.1007/s00296-021-04923-2
Goto, Manaka, et al. "ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04923-2
Goto M, Tsuchida Y, Terada K, Takahashi H, Sugimori Y, Komai T, Iwasaki Y, Shoda H, Fujio K. ANCA-associated vasculitis with protein-losing enteropathy is characterized by hypocomplementemia. Rheumatol Int. 2021 Jun 22; doi: 10.1007/s00296-021-04923-2. Epub 2021 Jun 22. PMID: 34156527.
Copy Download .nbib Format: NLM
Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review.

Rheumatology international

Üsküdar Cansu D, Cansu GB, Yildirim R, Dinler M, Tekin E, Ak Sivrikoz İ, Korkmaz C.
PMID: 34994813
Rheumatol Int. 2022 Jan 07; doi: 10.1007/s00296-021-05076-y. Epub 2022 Jan 07.

Immunoglobulin (Ig) G4-related disease (IgG4RD) is a chronic autoimmune disorder characterized by dense lymphoplasmacytic infiltrations and fibrosis of storiform pattern. The most typical manifestations include major salivary or lacrimal gland involvement, autoimmune pancreatitis, and retroperitoneal fibrosis. While the increase...

Cite
Üsküdar Cansu D, Cansu GB, Yildirim R, et al. Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review. Rheumatol Int. 2022;doi: 10.1007/s00296-021-05076-y.
Üsküdar Cansu, D., Cansu, G. B., Yildirim, R., Dinler, M., Tekin, E., Ak Sivrikoz, �. �., & Korkmaz, C. (2022). Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review. Rheumatology international, . https://doi.org/10.1007/s00296-021-05076-y
Üsküdar Cansu, Döndü, et al. "Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review." Rheumatology international vol. (2022). doi: https://doi.org/10.1007/s00296-021-05076-y
Üsküdar Cansu D, Cansu GB, Yildirim R, Dinler M, Tekin E, Ak Sivrikoz İ, Korkmaz C. Hypercalcemia in IgG4-related disease: coincidental or associated? Case based review. Rheumatol Int. 2022 Jan 07; doi: 10.1007/s00296-021-05076-y. Epub 2022 Jan 07. PMID: 34994813.
Copy Download .nbib Format: NLM
Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.

Rheumatology international

Kabeerdoss J, Sandhya P, Kurien BT, Scofield RH, Danda D.
PMID: 33963892
Rheumatol Int. 2021 May 08; doi: 10.1007/s00296-021-04878-4. Epub 2021 May 08.

No abstract available.

Cite
Kabeerdoss J, Sandhya P, Kurien BT, et al. Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome. Rheumatol Int. 2021;doi: 10.1007/s00296-021-04878-4.
Kabeerdoss, J., Sandhya, P., Kurien, B. T., Scofield, R. H., & Danda, D. (2021). Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome. Rheumatology international, . https://doi.org/10.1007/s00296-021-04878-4
Kabeerdoss, Jayakanthan, et al. "Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-04878-4
Kabeerdoss J, Sandhya P, Kurien BT, Scofield RH, Danda D. Correction to: In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome. Rheumatol Int. 2021 May 08; doi: 10.1007/s00296-021-04878-4. Epub 2021 May 08. PMID: 33963892.
Copy Download .nbib Format: NLM
Epidemiology and genetics of granulomatosis with polyangiitis.

Rheumatology international

Banerjee P, Jain A, Kumar U, Senapati S.
PMID: 34635927
Rheumatol Int. 2021 Dec;41(12):2069-2089. doi: 10.1007/s00296-021-05011-1. Epub 2021 Oct 11.

Granulomatosis with polyangiitis (GPA) previously known as Wegener's granulomatosis (WG) is a rare rheumatic disease affecting subjects of all ages. Prevalence and incidence of this systemic disease greatly varies across different ethnic groups. GPA is the commonest form of...

Cite
Banerjee P, Jain A, Kumar U, et al. Epidemiology and genetics of granulomatosis with polyangiitis. Rheumatol Int. 2021;41(12):2069-2089doi: 10.1007/s00296-021-05011-1.
Banerjee, P., Jain, A., Kumar, U., & Senapati, S. (2021). Epidemiology and genetics of granulomatosis with polyangiitis. Rheumatology international, 41(12), 2069-2089. https://doi.org/10.1007/s00296-021-05011-1
Banerjee, Pratibha, et al. "Epidemiology and genetics of granulomatosis with polyangiitis." Rheumatology international vol. 41,12 (2021): 2069-2089. doi: https://doi.org/10.1007/s00296-021-05011-1
Banerjee P, Jain A, Kumar U, Senapati S. Epidemiology and genetics of granulomatosis with polyangiitis. Rheumatol Int. 2021 Dec;41(12):2069-2089. doi: 10.1007/s00296-021-05011-1. Epub 2021 Oct 11. PMID: 34635927.
Copy Download .nbib Format: NLM
Correction to: Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.

Rheumatology international

Peinado-Acevedo JS, Varela DC, Hidrón A.
PMID: 33345288
Rheumatol Int. 2021 Sep;41(9):1681. doi: 10.1007/s00296-020-04758-3.

No abstract available.

Cite
Peinado-Acevedo JS, Varela DC, Hidrón A. Correction to: Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review. Rheumatol Int. 2021;41(9):1681doi: 10.1007/s00296-020-04758-3.
Peinado-Acevedo, J. S., Varela, D. C., & Hidrón, A. (2021). Correction to: Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review. Rheumatology international, 41(9), 1681. https://doi.org/10.1007/s00296-020-04758-3
Peinado-Acevedo, Juan Sebastián, et al. "Correction to: Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review." Rheumatology international vol. 41,9 (2021): 1681. doi: https://doi.org/10.1007/s00296-020-04758-3
Peinado-Acevedo JS, Varela DC, Hidrón A. Correction to: Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review. Rheumatol Int. 2021 Sep;41(9):1681. doi: 10.1007/s00296-020-04758-3. PMID: 33345288.
Copy Download .nbib Format: NLM
Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience.

Rheumatology international

Chattopadhyay A, Jain S, Naidu GSRSNK, Dhir V, Chhabria B, Acharya N, Muthu V, Singhal M, Savlania A, Vijayvergiya R, Jain S, Sharma A.
PMID: 34661711
Rheumatol Int. 2021 Oct 18; doi: 10.1007/s00296-021-05022-y. Epub 2021 Oct 18.

Arterial involvement, although rare, accounts for significant mortality and morbidity in patients of Behçet's disease (BD). There is paucity of data on arterial BD. The objective of this 5-year retrospective cohort study was to examine the clinical presentation, pattern...

Cite
Chattopadhyay A, Jain S, Naidu GSRSNK, et al. Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience. Rheumatol Int. 2021;doi: 10.1007/s00296-021-05022-y.
Chattopadhyay, A., Jain, S., Naidu, G. S. R. S. N. K., Dhir, V., Chhabria, B., Acharya, N., Muthu, V., Singhal, M., Savlania, A., Vijayvergiya, R., Jain, S., & Sharma, A. (2021). Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience. Rheumatology international, . https://doi.org/10.1007/s00296-021-05022-y
Chattopadhyay, Arghya, et al. "Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience." Rheumatology international vol. (2021). doi: https://doi.org/10.1007/s00296-021-05022-y
Chattopadhyay A, Jain S, Naidu GSRSNK, Dhir V, Chhabria B, Acharya N, Muthu V, Singhal M, Savlania A, Vijayvergiya R, Jain S, Sharma A. Clinical presentation and treatment outcomes of arterial involvement in Behçet's disease: a single-centre experience. Rheumatol Int. 2021 Oct 18; doi: 10.1007/s00296-021-05022-y. Epub 2021 Oct 18. PMID: 34661711.
Copy Download .nbib Format: NLM
Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study.

Rheumatology international

Alnaimat F, Mansour AT, Alduraidi H, Al-Qasem S, Hindi M, Rawashdeh T, Hassan E, Almustafa S, Hanbali R, Ababneh O, Kennedy BL.
PMID: 34661710
Rheumatol Int. 2021 Dec;41(12):2157-2166. doi: 10.1007/s00296-021-05028-6. Epub 2021 Oct 18.

Temporal artery biopsy (TAB) is one of the diagnostic tools to confirm the diagnosis of giant cell arteritis (GCA). We aim to evaluate the clinical and technical determinants of a positive biopsy. Demographics, clinical, technical, and laboratory data of...

Cite
Alnaimat F, Mansour AT, Alduraidi H, et al. Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study. Rheumatol Int. 2021;41(12):2157-2166doi: 10.1007/s00296-021-05028-6.
Alnaimat, F., Mansour, A. T., Alduraidi, H., Al-Qasem, S., Hindi, M., Rawashdeh, T., Hassan, E., Almustafa, S., Hanbali, R., Ababneh, O., & Kennedy, B. L. (2021). Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study. Rheumatology international, 41(12), 2157-2166. https://doi.org/10.1007/s00296-021-05028-6
Alnaimat, Fatima, et al. "Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study." Rheumatology international vol. 41,12 (2021): 2157-2166. doi: https://doi.org/10.1007/s00296-021-05028-6
Alnaimat F, Mansour AT, Alduraidi H, Al-Qasem S, Hindi M, Rawashdeh T, Hassan E, Almustafa S, Hanbali R, Ababneh O, Kennedy BL. Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study. Rheumatol Int. 2021 Dec;41(12):2157-2166. doi: 10.1007/s00296-021-05028-6. Epub 2021 Oct 18. PMID: 34661710.
Copy Download .nbib Format: NLM
Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis.

Rheumatology international

Zarco Montejo P, Almodóvar González R, De Higes-Martínez E, Gorgojo-Martínez JJ, Guijarro Herraiz C, López Navas MJ, Palacios D, Peláez Álvarez JC, Ruíz Genao D, Piedrafita B, Gómez S, Falkenbach E, Rebollo Laserna FJ, López Estebaranz JL.
PMID: 32274527
Rheumatol Int. 2020 Jun;40(6):969-981. doi: 10.1007/s00296-020-04573-w. Epub 2020 Apr 09.

The aim of this study was to generate practical recommendations to assist rheumatologists and dermatologists in the management of cardiovascular (CV) comorbidities in patients with moderate-to-severe psoriasis (MS-PSO) and psoriatic arthritis (PsA). A two-round Delphi study was conducted. A...

Cite
Zarco Montejo P, Almodóvar González R, De Higes-Martínez E, et al. Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis. Rheumatol Int. 2020;40(6):969-981doi: 10.1007/s00296-020-04573-w.
Zarco Montejo, P., Almodóvar González, R., De Higes-Martínez, E., Gorgojo-Martínez, J. J., Guijarro Herraiz, C., López Navas, M. J., Palacios, D., Peláez Álvarez, J. C., Ruíz Genao, D., Piedrafita, B., Gómez, S., Falkenbach, E., Rebollo Laserna, F. J., & López Estebaranz, J. L. (2020). Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis. Rheumatology international, 40(6), 969-981. https://doi.org/10.1007/s00296-020-04573-w
Zarco Montejo, Pedro, et al. "Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis." Rheumatology international vol. 40,6 (2020): 969-981. doi: https://doi.org/10.1007/s00296-020-04573-w
Zarco Montejo P, Almodóvar González R, De Higes-Martínez E, Gorgojo-Martínez JJ, Guijarro Herraiz C, López Navas MJ, Palacios D, Peláez Álvarez JC, Ruíz Genao D, Piedrafita B, Gómez S, Falkenbach E, Rebollo Laserna FJ, López Estebaranz JL. Delphi-based recommendations for the management of cardiovascular comorbidities in patients with psoriatic arthritis and moderate-to-severe psoriasis. Rheumatol Int. 2020 Jun;40(6):969-981. doi: 10.1007/s00296-020-04573-w. Epub 2020 Apr 09. PMID: 32274527.
Copy Download .nbib Format: NLM
A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis.

Rheumatology international

Chung TT, Ko HJ, Lau CS, Chung HY.
PMID: 32318800
Rheumatol Int. 2020 Jun;40(6):983-990. doi: 10.1007/s00296-020-04583-8. Epub 2020 Apr 21.

Tuberculosis (TB) is an important preventable infection in patients with rheumatoid arthritis (RA). To determine the risk of TB in patients with RA by comparing with those with non-specific back pain (NSBP), and to identify the risk factors in...

Cite
Chung TT, Ko HJ, Lau CS, et al. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis. Rheumatol Int. 2020;40(6):983-990doi: 10.1007/s00296-020-04583-8.
Chung, T. T., Ko, H. J., Lau, C. S., & Chung, H. Y. (2020). A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis. Rheumatology international, 40(6), 983-990. https://doi.org/10.1007/s00296-020-04583-8
Chung, Tin Tsun, et al. "A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis." Rheumatology international vol. 40,6 (2020): 983-990. doi: https://doi.org/10.1007/s00296-020-04583-8
Chung TT, Ko HJ, Lau CS, Chung HY. A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis. Rheumatol Int. 2020 Jun;40(6):983-990. doi: 10.1007/s00296-020-04583-8. Epub 2020 Apr 21. PMID: 32318800.
Copy Download .nbib Format: NLM
Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review.

Rheumatology international

Kounatidis D, Vadiaka M, Kouvidou C, Sampaziotis D, Skourtis A, Panagopoulos F, Konstantinou F, Vallianou NG.
PMID: 32318801
Rheumatol Int. 2020 Jun;40(6):997-1000. doi: 10.1007/s00296-020-04586-5. Epub 2020 Apr 21.

IgA vasculitis, formerly known as Henoch-Schonlein purpura (HSP), is the most common form of systemic vasculitis in children and is characterized by inflammation of the small vessels with typical deposition of IgA immune complexes. It is a leukocytoclastic type...

Cite
Kounatidis D, Vadiaka M, Kouvidou C, et al. Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review. Rheumatol Int. 2020;40(6):997-1000doi: 10.1007/s00296-020-04586-5.
Kounatidis, D., Vadiaka, M., Kouvidou, C., Sampaziotis, D., Skourtis, A., Panagopoulos, F., Konstantinou, F., & Vallianou, N. G. (2020). Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review. Rheumatology international, 40(6), 997-1000. https://doi.org/10.1007/s00296-020-04586-5
Kounatidis, Dimitris, et al. "Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review." Rheumatology international vol. 40,6 (2020): 997-1000. doi: https://doi.org/10.1007/s00296-020-04586-5
Kounatidis D, Vadiaka M, Kouvidou C, Sampaziotis D, Skourtis A, Panagopoulos F, Konstantinou F, Vallianou NG. Clostridioides difficile infection in a patient with immunoglobulin A vasculitis: a triggering factor or a rare complication of the disease? A case-based review. Rheumatol Int. 2020 Jun;40(6):997-1000. doi: 10.1007/s00296-020-04586-5. Epub 2020 Apr 21. PMID: 32318801.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 344 entries